GIRENTUXIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Investigational

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 01:56:11 GMT 2025` Edited by `admin` on `Wed Apr 02 01:56:11 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	MOUSE CHIMERIC
Sequence Type	COMPLETE
Record UNII	539B57DFJF
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CA9-SCAN CG250

Preferred Name

English

GIRENTUXIMAB

Official Name

English

GIRENTUXIMAB [USAN]

Common Name

English

RENCAREX

Brand Name

English

girentuximab [INN]

Common Name

English

Girentuximab [WHO-DD]

Common Name

English

WX-G250

Code

English

CG250

Code

English

GIRENTUXIMAB [MART.]

Common Name

English

CG-250

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C129822

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

FDA ORPHAN DRUG

139000

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

NCI_THESAURUS

C20401

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

FDA ORPHAN DRUG

133300

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

Code System Code Type Description

USAN

WW-150

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

INN

9116

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

ChEMBL

CHEMBL1743027

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

CAS

916138-87-9

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

NCI_THESAURUS

C1960

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

WIKIPEDIA

Girentuximab

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

DRUG BANK

DB05304

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

EVMPD

SUB129650

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

FDA UNII

539B57DFJF

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

SMS_ID

100000155597

Created by admin on Wed Apr 02 01:56:11 GMT 2025 , Edited by admin on Wed Apr 02 01:56:11 GMT 2025

PRIMARY

From	To
1_22	1_96
1_146	1_202
1_263	1_323
1_369	1_427
2_22	2_96
2_146	2_202
2_263	2_323
2_369	2_427
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194
1_222	3_214
2_222	4_214
1_228	2_228
1_231	2_231

Glycosylation Link Type	Site
N	1_299
N	2_299

Related Record Type Details


					P0I0FT82VK

GIRENTUXIMAB I-124

INGREDIENT -> STARTING MATERIAL


					A0JY916TKK

CARBONIC ANHYDRASE 9

TARGET -> INHIBITOR

Related Record Type Details


					539B57DFJF

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL